Publications of Institute of Radiooncology - OncoRay (from 2013)

181 Publications
Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data
Lühr, A.; Löck, S.; Jakobi, A.; Stützer, K.; Bandurska-Luque, A.; Vogelius, I. R.; Enghardt, W.; Baumann, M.; Krause, M.
Corresponding author: Lühr, A. DKTK, OncoRay, DKFZ, HZDR

Melanoma Brain Metastases
Brütting, J.; Rauschenberg, R.; Troost, E. G. C.; Meier, F.; Garzarolli, M.

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Zschaeck, S.; Löck, S.; Leger, S.; Haase, R.; Bandurska-Luque, A.; Appold, S.; Kotzerke, J.; Zips, D.; Richter, C.; Gudziol, V.; Schreiber, A.; Zöphel, K.; Baumann, M.; Krause, M.
Corresponding author: Zschaeck, Sebastian Uniklinikum Dresden

Targeting stem cells in radiation oncology
Coppes, R.; Dubrovska, A

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
Zindler, J.; Jochems, A.; Lagerwaard, F.; Beumer, R.; Troost, E.; Eekers, D.; Compter, I.; van der Toorn, P.-P.; Essers, M.; Oei, B.
Corresponding author: Zindler, Jd MAASTRO clinic

Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Wijsman, R.; Dankers, F.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L. F.; Bussink, J.

3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation
Eke, I.; Hehlgans, S.; Sandfort, V.; Cordes, N.
  • International Journal of Oncology 48(2016)1, 313-321

Ambidextrous Idea Generation-Antecedents and Outcomes
Gurtner, S.; Reinhardt, R.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baumann, M.; DKTK-ROG

A Compton camera prototype for prompt gamma medical imaging
Thirolf, P. G.; Aldawood, S.; Böhmer, M.; Bortfeldt, J.; Castelhano, I.; Dedes, G.; Fiedler, F.; Gernhäuser, R.; Golnik, C.; Helmbrecht, S.; Hueso-González, F.; von D. Kolff, H.; Kormoll, T.; Lang, C.; Liprandi, S.; Lutter, R.; Marinšek, T.; Maier, L.; Pausch, G.; Petzoldt, J.; Römer, K.; Schaart, D.; Parodi, K.

The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
Storch, K.; Cordes, N.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.
Offersen, B. V.; Boersma, L. J.; Kirkove, C.; Hol, S.; Aznar, M. C.; Sola, A. B.; Kirova, Y. M.; Pignol, J.-P.; Remouchamps, V.; Verhoeven, K.; Weltens, C.; Arenas, M.; Gabrys, D.; Kopek, N.; Krause, M.; Lundstedt, D.; Marinko, T.; Montero, A.; Yarnold, J.; Poortmans, P.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Linge, A.; Löck, S.; Krenn, C.; Appold, S.; Lohaus, F.; Nowak, A.; Gudziol, V.; Baretton, G. B.; Buchholz, F.; Baumann, M.; Krause, M.

Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter?
Lattermann, A.; Baumann, M.; Krause, M.

Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells
Dickreuter, E.; Eke, I.; Krause, M.; Borgmann, K.; van Vugt, M. A.; Cordes, N.

Bridging the valley of death: The new Radiotherapy & Oncology section “First in man - Translational innovations in radiation oncology.”
Baumann, M.; Overgaard, J.

Polyphenols delivery by polymeric materials: challenges in cancer treatment.
Vittorio, O.; Curcio, M.; Cojoc, M; Goya, G.; Hampel, S.; Iemma, F.; Dubrovska, A; Cirillo, G.

Nanoparticles for radiooncology: Mission, vision, challenges.
L Kunz-Schughart ; A Dubrovska; C Peitzsch ; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M.; Hampel, S.; Cirillo, G.; Iemmae, F.; Tietze, R.; Alexiou, C.; Stephan, H.; Zarschlerg, K.; Vittorio, O.; Kavallaris, M.; Parak, W.; Mädler, L.; Pokhrel, S.

Feasibility of proton pencil beam scanning treatment of free-breathing lung cancer patients
Jakobi, A.; Perrin, R.; Knopf, A.; Richter, C.ORC
Corresponding author: Jakobi, Annika OncoRay, Faculty of Medicine, University Hospital Dresden, TUD, HZDR

Nanoparticles for radiooncology: Mission, vision, challenges
Kunz-Schughart, L. A.; Dubrovska, A.; Peitzsch, C.; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M. H.; Hampel, S.; Cirillo, G.; Iemma, F.; Tietze, R.; Alexiou, C.; Stephan, H.ORC; Zarschler, K.; Vittorio, O.; Kavallaris, M.; Parak, W. J.; Mädler, L.; Pokhrel, S.

Toward Distributed Conduction of Large-Scale Studies in Radiation Therapy and Oncology: Open-Source System Integration Approach
Skripcak, T.; Just, U.; Simon, M.; Buttner, D.; Lühr, A.; Baumann, M.; Krause, M.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.
Linge, A.; Löck, S.; Gudziol, V.; Nowak, A.; Lohaus, F.; von Neubeck, C.; Jütz, M.; Abdollahi, A.; Debus, J.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Welz, S.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Baumann, M.; Krause, M.

Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
Wack, L. J.; Mönnich, D.; Yaromina, A.; Zips, D.; Baumann, M.; Thorwarth, D.

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Zegers, C. M. L.; Hoebers, F. J. P.; van Elmpt, W.; Bons, J. A.; Öllers, M. C.; Troost, E. G. C.; Eekers, D.; Balmaekers, L.; Arts-Pechtold, M.; Mottaghy, F. M.; Lambin, P.

Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch, C.; Bergmann, R.; Brüchner, K.; Mosch, B.; Yaromina, A.; Krause, M.; Zips, D.; Troost, E. G. C.; Löck, S.; Kotzerke, J.; Steinbach, J.; Thames, H.; Baumann, M.; Beuthien-Baumann, B.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge, A.; Lohaus, F.; Löck, S.; Nowak, A.; Gudziol, V.; Valentini, C.; von Neubeck, C.; Jütz, M.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Krause, M.; Baumann, M.

Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Eldesoky, A. R.; Yates, E. S.; Nyeng, T. B.; Thomsen, M. S.; Nielsen, H. M.; Poortmans, P.; Kirkove, C.; Krause, M.; Kamby, C.; Mjaaland, I.; Blix, E. S.; Jensen, I.; Berg, M.; Lorenzen, E. L.; Taheri-Kadkhoda, Z.; Offersen, B. V.

The Clinical Target Volume in Lung, Head-and-neck, and Esophageal Cancer: Lessons from Pathological Measurement and Recurrence Analysis
Apolle, R.ORC; Rehm, M.; Bortfeld, T.; Baumann, M.; Troost, E.

The cancer cell adhesion resistome: mechanisms, targeting and translational approaches
Dickreuter, E.; Cordes, N.
Corresponding author: Dickreuter, E.

Vertebral fractures – An underestimated side-effect in patients treated with radio(chemo)therapy
Pilz, K.; Hoffmann, A. L.; Baumann, M.; Troost, E. G. C.

Technical feasibility of integrating 7 T anatomical MRI in image‑guided radiotherapy of glioblastoma: a preparatory study
Compter, I.; Peerlings, J.; Eekers, D. B. P.; Postma, A. A.; Ivanov, D.; Wiggins, C. J.; Kubben, P.; Küsters, B.; Wesseling, P.; Ackermans, L.; Schijns, O. E. M. G.; Lambin, P.; Hoffmann, A. L.

Radiation oncology in the era of precision medicine
Baumann, M.; Krause, M.; Overgaard, J.; Debus, J.; Bentzen, S. M.; Daartz, J.; Richter, C.; Zips, D.; Bortfeld, T.

PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
Zschaeck, S.; Simon, M.; Löck, S.; Troost, E. G. C.; Stützer, K.; Wohlfahrt, P.; Appold, S.; Makocki, S.; Bütof, R.; Richter, C.; Baumann, M.; Krause, M.

Comment on „Dosimetric comparison of stopping power calibration with dual-energy CT and single-energy CT in proton therapy treatment planning“ [Med. Phys. 43(6), 2845-2854 (2016)]
Wohlfahrt, P.ORC; Möhler, C.ORC; Greilich, S.; Richter, C.
Corresponding author: Wohlfahrt, P. OncoRay, FWMP (HZDR)

Evaluation of a deformable registration algorithm for subsequent lung computed tomography imaging during radiochemotherapy
Stützer, K.; Haase, R.; Lohaus, F.; Barczyk, S.; Exner, F.; Löck, S.; Rühaak, J.; Lassen-Schmidt, B.; Corr, D.; Richter, C.

The Why and How of Amino Acid Analytics in Cancer Diagnostics and Therapy
Manig, F.; Kuhne, K.; von Neubeck, C.; Schwarzenbolz, U.; Yu, Z.; Kessler, B. M.; Pietzsch, J.; Kunz-Schughart, L. A.

Methodological accuracy of image-based electron-density assessment using dual-energy computed tomography
Möhler, C.ORC; Wohlfahrt, P.ORC; Richter, C.; Greilich, S.
Corresponding author: Wohlfahrt, Patrick OncoRay, Institut of Radiooncology (HZDR)

The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression
Tyutyunnykova, A.; Telegeev, G.; Dubrovska, A.
Corresponding author: Dubrovska, Anna HZDR, OncoRay, TU Dresden

Cancer stem cells: the root of tumor recurrence and metastases
Peitzsch, C.; Tyutyunnykova, A.; Pantel, K.; Dubrovska, A.
Corresponding author: Peitzsch, Claudia OncoRay - National Center for Radiation Research in Oncology, NCT

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.
Martinussen, H. M. A.; Reymen, B.; Wanders, R.; Troost, E. G. C.; Dingemans, A.-M. C.; Öllers, M.; Houben, R.; de Ruysscher, D.; Lambin, P.; van Baardwijk, A.

Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated with intensity-modulated (chemo-)radiotherapy
Dankers, F.; Wijsman, R.; Troost, E.; Monshouwer, R.; Bussink, J.; Hoffmann, A.

Digital high-pass filter deconvolution by means of an infinite impulse response filter
Födisch, P.; Wohsmann, J.; Lange, B.; Schönherr, J.; Enghardt, W.; Kaever, P.

Charge-sensitive front-end electronics with operational amplifiers for CdZnTe detectors
Födisch, P.; Berthel, M.; Lange, B.; Kirschke, T.; Enghardt, W.; Kaever, P.

Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: incidence and proposed risk factors
Wink, K. C. J.; van Baardwijk, A.; Troost, E. G. C.; de Ruysscher, D.

Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin
Koppenhagen, P.; Dickreuter, E.; Cordes, N.
Corresponding author: Koppenhagen, P. TU Dresden

Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
Vanneste, B. G. L.; Hoffmann, A. L.; van Lin, E. N.; van de Voorde, L.; Pinkawa, M.; Lambin, P.

[18F]FDG-PET/CT based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches
de Jong, E.; van Elmpt, W.; Leijenaar, R.; Hoekstra, O.; Groen, H.; Smit, E.; Boellaard, R.; van der Noort, V.; Troost, E.; Lambin, P.; Dingemans, A.

Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial
Eekers, D. B. P.; Roelofs, E.; Jelen, U.; Kirk, M.; Granzier, M.; Ammazzalorso, F.; Ahn, P. H.; Janssens, G. O. R. J.; Hoebers, F. J. P.; Friedmann, T.; Solberg, T.; Walsh, S.; Troost, E. G. C.; Kaanders, J. H. A. M.; Lambin, P.

Clinical implementation of dual-energy CT for proton treatment planning on pseudo-monoenergetic CT scans
Wohlfahrt, P.; Möhler, C.; Hietschold, V.; Menkel, S.; Greilich, S.; Krause, M.; Baumann, M.; Enghardt, W.; Richter, C.

Range prediction for tissue mixtures based on dual-energy CT
Möhler, C.; Wohlfahrt, P.; Richter, C.; Greilich, S.

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC 3 prostate cancer in vitro and in vivo
Liebscher, S.; Koi, L.; Löck, S.; Muders, M. H.; Krause, M.
Corresponding author: Liebscher, Steffi
Corresponding author: Koi, Lydia
Corresponding author: Löck, Steffen
Corresponding author: Muders, M. H.
Corresponding author: Krause, Mechthild
  • Open Access LogoClinical and Translational Radiation Oncology (2017)

BEMER electromagnetic field therapy reduces cancer cell radioresistance by enhanced ROS formation and induced DNA damage
Storch, K.; Dickreuter, E.; Artati, A.; Adamski, J.; Cordes, N.
Corresponding author: Cordes, N.

Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
Wink, K. C. J.; Belderbos, J. S. A.; Dieleman, E. M. T.; Rossi, M.; Rasch, C. R. N.; Damhuis, R. A. M.; Houben, R. M. A.; Troost, E. G. C.

An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch, C.; Cojoc, M.; Hein, L.; Kurth, I.; Mäbert, K.; Trautmann, F.; Klink, B.; Schröck, E.; Wirth, M. P.; Krause, M.; Stakhovsky, E. A.; Telegeev, G. D.; Novotny, V.; Toma, M.; Muders, M.; Baretton, G. B.; Frame, F. M.; Maitland, N. J.; Baumann, M.; Dubrovska, A.

[Melanoma brain metastases : Treatment options]. [Hirnmetastasen des malignen Melanoms].
Rauschenberg, R.; Tabatabai, G.; Troost, E. G. C.; Garzarolli, M.; Beissert, S.; Meier, F.

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
Zscheppang, K.; Kurth, I.; Wachtel, N.; Dubrovska, A.; Kunz-Schughart, L. A.; Cordes, N.

Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk, B.; Schwager, C.; Deffaa, O.; Dyckhoff, G.; Warta, R.; Linge, A.; Krause, M.; Weichert, W.; Baumann, M.; Herold-Mende, C.; Debus, J.; Abdollahi, A.

Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation.
Carvalho, S.; Troost, E. G. C.; Bons, J.; Menheere, P.; Lambin, P.; Oberije, C.

Precise image-guided irradiation of small animals: a flexible non-profit platform
Tillner, F.; Thute, P.; Löck, S.; Dietrich, A.; Fursov, A.; Haase, R.; Lukas, M.; Rimarzig, B.; Sobiella, M.; Krause, M.; Baumann, M.; Bütof, R.; Enghardt, W.

Design and implementation of a robust and cost-effective double-scattering system at a horizontal proton beamline
Helmbrecht, S.; Baumann, M.; Fiedler, F.; Enghardt, W.; Krause, M.; Lühr, A.

Prediction and compensation of magnetic beam deflection in MR-integrated proton therapy: A method optimized regarding accuracy, versatility and speed
Schellhammer, S. M.; Hoffmann, A. L.

Stakeholder integration in new product development – A systematic analysis of drivers and firm capabilities
Martin, M. V.; Reinhardt, R.; Gurtner, S.

In-beam PET at clinical proton beams with pile-up rejection
Helmbrecht, S.; Enghardt, W.; Fiedler, F.; Iltzsche, M.; Pausch, G.; Tintori, C.; Kormoll, T.

How to catch the generation Y: Identifying consumers of ecological innovations among youngsters
Gurtner, S.; Soyez, K.

Prompt gamma rays detected with a BGO block Compton camera reveal range deviations of therapeutic proton beams
Hueso-González, F.; Pausch, G.; Petzoldt, J.; Römer, K. E.; Enghardt, W.

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.
Hofheinz, F.; Bütof, R.; Apostolova, I.; Zöphel, K.; Steffen, I. G.; Amthauer, H.; Kotzerke, J.; Baumann, M.; van den Hoff, J.
Corresponding author: Hofheinz, Frank Helmholtz-Zentrum Dresden-Rossendorf, PET Center, Institute of Radiopharmaceutical Cancer Research

Wertorientierung im Technologiemanagement von Krankenhäusern
Gurtner, S.; Gurtner, K.
  • mt-medizintechnik 2(2015), 57-60

Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer
Cobben, D. C. P.; de Boer, H. C. J.; Tijssen, R. H.; Rutten, E. G. G. M.; van Vulpen, M.; Peerlings, J.; Troost, E. G. C.; Hoffmann, A. L.; van Lier, A. L. H. M. W.

Magnetic Nanoparticles in tumour xenografts detected and quantified by Micro-Computer Tomography
Bayer, K.; Eckert, H.; Wiekhorst, F.; Trahms, L.; Krause, M.; Odenbach, S.

NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy
Jakobi, A.; Stützer, K.; Bandurska-Luque, A.; Löck, S.; Haase, R.; Wack, L.-J.; Mönnich, D.; Thorwarth, D.; Perez, D.; Lühr, A.; Zips, D.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C.

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicenter study of the German cancer consortium radiation oncology group (DKTK-ROG)
Balermpas, P.; Rödel, F.; Rödel, C.; Krause, M.; Linge, A.; Lohaus, F.; Baumann, M.; Tinhofer, I.; Budach, V.; Gkika, E.; Stuschke, M.; Avlar, M.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Bayer, C.; Stangl, S.; Belka, C.; Pigorsch, S.; Multhoff, G.; Combs, S. E.; Mönnich, D.; Zips, D.; Fokas, E.

Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy
Jakobi, A.; Lühr, A.; Stützer, K.; Bandurska-Luque, A.; Löck, S.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C.
Corresponding author: Krause, M. OncoRay; DKTK partner site Dresden; DKFZ; Strahlentherapie - Universitätsklinikum - Medizinische Fakultät; HZDR

A synchronous Gigabit Ethernet protocol stack for high-throughput UDP/IP applications
Födisch, P.; Lange, B.; Sandmann, J.; Büchner, A.; Enghardt, W.; Kaever, P.

Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI
Petr, J.; Platzek, I.; Seidlitz, A.; Mutsaerts, H. J. M. M.; Hofheinz, F.; Schramm, G.; Maus, J.; Beuthien-Baumann, B.; Krause, M.; van den Hoff, J.
Corresponding author: Petr, Jan

Stereotactic radiotherapy augments the immune response / Die stereotaktische Strahlentherapie unterstützt die Immunantwort
Troost, E. G. C.

Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake.
Trani, D.; Yaromina, A.; Dubois, L.; Granzier, M.; Peeters, S. G.; Biemans, R.; Nalbantov, G.; Lieuwes, N.; Reniers, B.; Troost, E. E.; Verhaegen, F.; Lambin, P.

HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.
Lohaus, F.; Linge, A.; Baumann, M.

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Kurth, I.; Hein, L.; Mäbert, K.; Peitzsch, C.; Koi, L.; Cojoc, M.; Kunz-Schughart, L.; Baumann, M.; Dubrovska, A.

Global Task Force on Radiotherapy for Cancer Control.
Jaffray, D. A.; Knaul, F. M.; Atun, R.; Adams, C.; Barton, M. B.; Baumann, M.; Lievens, Y.; Lui, T. Y.; Rodin, D. L.; Rosenblatt, E.; Torode, J.; van Dyk, J.; Vikram, B.; Gospodarowicz, M.

Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.
Hofheinz, F.; Lougovski, A.; Zöphel, K.; Hentschel, M.; Steffen, I. G.; Apostolova, I.; Wedel, F.; Buchert, R.; Baumann, M.; Brenner, W.; Kotzerke, J.; van den Hoff, J.

Proton therapy of pediatric rhabdomyosarcoma: Same tumor control as photon therapy, with less adverse effects / Protonentherapie von Rhabdomyosarkompatienten im Kindesalter: Gleiche lokale Tumorkontrolle wie bei Photonentherapie mit weniger Nebenwirkungen
Gurtner, K.; Baumann, M.

Comprehensive analysis of signal transduction in three-dimensional ECM-based tumor cell cultures.
Eke, I.; Hehlgans, S.; Zong, Y.; Cordes, N.

Cell-ECM interactions control DDR
Dickreuter, E.; Cordes, N.
  • Open Access LogoOncoscience 2(2015)8, 679-680

Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach, V.; Stromberger, C.; Poettgen, C.; Baumann, M.; Budach, W.; Grabenbauer, G.; Marnitz, S.; Olze, H.; Wernecke, K. D.; Ghadjar, P.

Expanding global access to radiotherapy
Atun, R.; Jaffray, D. A.; Barton, M. B.; Bray, F.; Baumann, M.; Vikram, B.; Hanna, T. P.; Knaul, F. M.; Lievens, Y.; Lui, T. Y.; Milosevic, M.; O'Sullivan, B.; Rodin, D. L.; Rosenblatt, E.; van Dyk, J.; Yap, M. L.; Zubizarreta, E.; Gospodarowicz, M.

Scintillator-Based High-Throughput Fast Timing Spectroscopy for Real-Time Range Verification in Particle Therapy
Pausch, G.; Petzoldt, J.; Berthel, M.; Enghardt, W.; Fiedler, F.; Golnik, C.; Hueso-González, F.; Lentering, R.; Römer, K.; Ruhnau, K.; Stein, J.; Wolf, A.; Kormoll, T.
  • IEEE Transactions on Nuclear Science 63(2016)2, 664-672
  • Lecture (Conference)
    13th International Conference on Scintillators and their Applications (SCINT), 07.-12.06.2015, Berkeley, USA

Approval procedures for clinical trials in the field of radiation oncology
Simon, M.; Habeck, M.; Büttner, D.; Habeck, U.; Nölling, T.; Krause, M.; Brix, G.; Willich, N.; Wenz, F.; Schmidberger, H.; Debus, J.; Baumann, M.

Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients
Wijsman, R.; Grootjans, W.; Troost, E. G.; van der Heijden, E. H.; Visser, E. P.; de Geus-Oei, L.-F.; Bussink, J.

First clinical application of a prompt gamma based in vivo proton range verification
Richter, C.; Pausch, G.; Barczyk, S.; Priegnitz, M.; Keitz, I.; Thiele, J.; Smeets, J.; Vander Stappen, F.; Bombelli, L.; Fiorini, C.; Hotoiu, L.; Perali, I.; Prieels, D.; Enghardt, W.; Baumann, M.

Imaging-Based Treatment Adaptation in Radiation Oncology
Troost, E. G.; Thorwarth, D.; Oyen, W. J.

Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?
Persoon, L. C.; Podesta, M.; Hoffmann, L.; Sanizadeh, A.; Schyns, L. E.; de Ruiter, B. M.; Nijsten, S. M.; Muren, L. P.; Troost, E. G.; Verhaegen, F.

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks, L. E.; Derks, J. L.; Postmus, P. E.; Damhuis, R. A.; Houben, R. M.; Troost, E. G.; Hochstenbag, M. M.; Smit, E. F.; Dingemans, A. M.

Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription
Zindler, J. D.; Thomas, C. R.; Hahn, S. M.; Hoffmann, A. L.; Troost, E. G. C.; Lambin, P.

Requirements for a Compton camera for in-vivo range verification of proton therapy
Rohling, H.; Priegnitz, M.; Schöne, S.; Schumann, A.; Enghardt, W.; Hueso-Gonzalez, F.; Pausch, G.; Fiedler, F.

From prompt gamma distribution to dose: A novel approach combining an evolutionary algorithm and filtering based on gaussian-powerlaw convolutions
Schumann, A.; Priegnitz, M.; Schoene, S.; Enghardt, W.; Rohling, H.; Fiedler, F.

Advances in radiotherapy special feature.
Krause, M.; Supiot, S.

Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia - a simulation study.
Wack, L. J.; Mönnich, D.; van Elmpt, W.; Zegers, C. M.; Troost, E. G.; Zips, D.; Thorwarth, D.

Valproic acid modulates radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells.
Artacho-Cordón, F.; Ríos-Arrabal, S.; Olivares-Urbano, M. A.; Storch, K.; Dickreuter, E.; Muñoz-Gámez, J. A.; León, J.; Calvente, I.; Torné, P.; Salinas, M. D.; Cordes, N.; Núñez, M. I.

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
Hausmann, C.; Temme, A.; Cordes, N.; Eke, I.

Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure
Zschaeck, S.; Haase, R.; Abolmaali, N.; Perrin, R.; Stützer, K.; Appold, S.; Steinbach, J.; Kotzerke, J.; Zips, D.; Richter, C.; Gudziol, V.; Krause, M.; Zöphel, K.; Baumann, M.

Pages: [All] [1] [2]